A Biosynthetic Pathway Generating 12-Hydroxy-5,8,14-eicosatrienoic Acid from Arachidonic Acid Is Active in Mouse Skin Microsomes
- 1 January 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 316 (1) , 371-379
- https://doi.org/10.1124/jpet.105.093922
Abstract
The epidermis expresses cyclooxygenases, lipoxygenases, and cytochromes P450, which utilize arachidonic acid to generate a diverse array of lipid mediators affecting epidermal cellular differentiation and functions. Recent studies show that mouse epidermis expresses CYP2B19, a keratinocyte-specific epoxygenase that generates 11,12- and 14,15-epoxyeicosatrienoic (EET) acids from arachidonate. We studied CYP2B19-dependent metabolism in mouse epidermal microsomes, reconstituted in the presence of [1-14C]arachidonic acid. The majority of the 14C products formed independently of NADPH, indicative of robust epidermal cyclooxygenase and lipoxygenase activities. We studied two NADPH-dependent products generated in a highly reproducible manner from arachidonate. One of these (product I) coeluted with the CYP2B19 product 14,15-EET on a reversed-phase high-performance liquid chromatography (HPLC) system; there was no evidence for other regioisomeric EET products. Further analyses proved that product I was not an epoxy fatty acid, based on different retention times on a normal-phase HPLC system and failure of product I to undergo hydrolysis in acidic solution. We analyzed purified epidermal 14C products by liquid chromatography negative electrospray ionization mass spectrometry. Structures of the NADPH-dependent products were confirmed to be 12-oxo-5,8,14-eicosatrienoic acid (I) and 12-hydroxy-5,8,14-eicosatrienoic acid (II). This was the first evidence for a 12-hydroxy-5,8,14-eicosatrienoic acid biosynthetic pathway in mouse epidermis. Epidermal microsomes also generated 12-hydroperoxy, 12-hydroxy, and 12-oxo eicosatetraenoic acids from arachidonate, possible intermediates in the 12-hydroxy-5,8,14-eicosatrienoic acid biosynthetic pathway. These results predict that hydroxyeicosatrienoic acids are synthesized from arachidonate in human epidermis. This would have important implications for human skin diseases given the known pro- and anti-inflammatory activities of stereo- and regioisomeric hydroxyeicosatrienoic acids.This publication has 38 references indexed in Scilit:
- Epoxyeicosatrienoic Acids Activate Transglutaminases in Situ and Induce Cornification of Epidermal KeratinocytesJournal of Biological Chemistry, 2003
- Stereoselective Biosynthesis of Hepoxilin B3 in Human EpidermisJournal of Investigative Dermatology, 2000
- Differentiating Keratinocytes Express a Novel Cytochrome P450 Enzyme, CYP2B19, Having Arachidonate Monooxygenase ActivityJournal of Biological Chemistry, 1998
- High Affinity Binding Sites for 12(R)-Hydroxyeicosatrienoic Acid [12(R)-HETrE] in Microvessel Endothelial CellsJournal of Ocular Pharmacology and Therapeutics, 1997
- Enhancement of Delayed Hypersensitivity Inflammatory Reactions in Guinea Pig Skin by 12(R)-Hydroxy-5,8,14-Eicosatrienoic AcidJournal of Investigative Dermatology, 1995
- Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Arachidonic Acid Metabolism Varies with the State of Differentiation in Density Gradient-Separated Mouse Epidermal CellsJournal of Investigative Dermatology, 1990
- Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesionsBiochemical and Biophysical Research Communications, 1986
- Arachidonic acid metabolism by isolated epidermal basal and differentiated keratinocytes from the hairless mouseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Changes in Arachidonic Acid Metabolism in UV-Irradiated Hairless Mouse SkinJournal of Investigative Dermatology, 1983